The E3 ubiquitin ligase Itch regulates death receptor and cholesterol trafficking to affect TRAIL-mediated apoptosis
Abstract
The activation of apoptosis signalling by TRAIL (TNF-related apoptosis-inducing ligand) through receptor binding is a fundamental mechanism of cell death induction and is often perturbed in cancer cells to enhance their cell survival and treatment resistance. Ubiquitination plays an important role in the regulation of TRAIL-mediated apoptosis, and here we investigate the role of the E3 ubiquitin ligase Itch in TRAIL-mediated apoptosis in oesophageal cancer cells. Knockdown of Itch expression resulted in resistance to TRAIL-induced apoptosis, caspase-8 activation, Bid cleavage and also promoted cisplatin resistance. Whilst the assembly of the death-inducing signalling complex (DISC) at the plasma membrane was not perturbed relative to the control, the TRAIL-R2 receptor was mis-localised in the Itch-knockdown cells. Further, we observed significant mitochondrial widening with an increased cholesterol content. An inhibitor of cholesterol trafficking, U18666A, was able to replicate some of the effects of Itch knockdown, including protection from TRAIL-induced apoptosis, reduced caspase-8 activation, Bid cleavage and Cisplatin resistance. This study highlights the importance of Itch in regulating the crosstalk between mitochondrial cholesterol and TRAIL-induced apoptosis.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TRAIL induces caspase-dependent cleavage of specific components of the clathrin-mediated endocytosis machinery
David A. Lawrence, Scot A. Marsters, … Avi Ashkenazi·bioRxiv·Oct 24, 2024
- MAP kinase ERK5 modulates cancer cell sensitivity to extrinsic apoptosis induced by death-receptor agonists and Natural Killer cells
S. Espinosa-Gil, S. Ivanova, … J. M. Lizcano·bioRxiv·Mar 22, 2023
- Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Progression in Cholangiocarcinoma
E. Loeuillard, B. Li, … S. I. Ilyas·bioRxiv·May 24, 2023
- TRAIL-induces Src mediated MEK/ERK, SMAD3 and β-catenin signalling in apoptosis resistant NSCLC cells
M. d. Looff, W. S. Heng, … F. A. E. Kruyt·bioRxiv·Aug 10, 2022
- The Discovery of Small Molecule Inhibitors of cFLIP that Sensitise Tumour Cells to TRAIL
Gilda Giancotti, Rhiannon French, … Andrea Brancale·Academia oncology.Peer-reviewed·Apr 29, 2025
- TRAIL signalling promotes entosis in colorectal cancer
E. Bozkurt, H. Dussmann, … J. H. M. Prehn·bioRxiv·Sep 29, 2020